News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Octapharma AG Hosts Symposium at WFH World Congress on Meeting the Challenges of Von Willebrand Disease (VWD) Diagnosis and Treatment



7/25/2012 9:35:44 AM

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, a leading producer of human proteins for life saving therapies, sponsored a symposium entitled “Meeting the challenges of VWD diagnosis and treatment- Which problems have we solved?” This symposium was held on July 11, 2012 during the 30th Congress of World Federation of Haemophilia in Paris, France.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES